Explain the mechanism of acute respiratory distress syndrome

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content. Let me compile the full explanation.

Mechanism of Acute Respiratory Distress Syndrome (ARDS)

Definition and Core Concept

ARDS is a form of noncardiogenic pulmonary edema characterized by diffuse alveolar damage (DAD), refractory hypoxemia, and severely reduced lung compliance. Unlike cardiogenic pulmonary edema (which is hydrostatic), ARDS edema is exudative — the alveolar-capillary barrier becomes pathologically permeable, allowing protein-rich fluid to flood the airspaces. — Murray & Nadel's Textbook of Respiratory Medicine

Triggers: Direct vs. Indirect Lung Injury

Direct (Pulmonary)Indirect (Non-pulmonary)
Pneumonia (bacterial, viral, COVID-19)Sepsis
Aspiration of gastric contentsMajor trauma
Pulmonary contusionMultiple blood transfusions
Toxic inhalation / near-drowningPancreatitis
Reperfusion injury (post-transplant)Drug overdose / cardiopulmonary bypass
The highest-risk triggers are sepsis, major trauma, aspiration, and massive transfusion. Having multiple risk factors additively increases ARDS incidence. — Murray & Nadel's

Phases of Pathology (Diffuse Alveolar Damage)

ARDS proceeds through three overlapping stages:
1. Exudative phase (0–7 days)
  • Hyaline membrane formation (cellular debris + proteins + surfactant components)
  • Protein-rich fluid fills alveolar spaces
  • Widespread epithelial disruption
  • Massive neutrophil infiltration of interstitium and airspaces
2. Proliferative phase (days 7–21)
  • Hyaline membranes are reorganized
  • Fibrosis begins to appear
  • Pulmonary capillary obliteration
  • Interstitial and alveolar collagen deposition
  • Neutrophil numbers decrease
3. Fibrotic phase (>2 weeks in persistent ARDS)
  • Frank pulmonary fibrosis in a subset of patients
  • Elevated N-terminal procollagen peptide III detectable in BAL fluid as early as 24 hours — indicating that fibroproliferation may begin simultaneously with, rather than after, the inflammatory injury

The Alveolar-Capillary Barrier: Core Mechanism

The alveolar-capillary barrier has two components:
Pulmonary microvascular endothelium
  • Normally, the endothelium is a semi-permeable barrier, but under inflammatory conditions it becomes highly permeable
  • Neutrophil-derived oxidants, proteases, and cytokines directly injure endothelial cells
  • Loss of endothelial integrity → protein-rich edema fluid leaks into the interstitium and alveoli
Alveolar epithelium (Type I and Type II pneumocytes)
  • Type I cells (covering ~95% of the alveolar surface) are exquisitely sensitive to injury; their death causes massive permeability failure
  • Type II cells (normally 5% of surface) are more resilient; they are responsible for surfactant production and for regenerating Type I cells during repair
  • In ARDS, Type II cell dysfunction leads to surfactant deficiency, causing alveolar collapse and worsening shunt
  • Normally, Type II cells reabsorb alveolar fluid via active sodium transport (ENaC channels); in ARDS this fluid-clearance capacity is severely impaired

Neutrophil-Mediated Injury: The Central Effector

Neutrophil activation and sequestration in the pulmonary microvasculature is the central mechanism of alveolar injury:
  1. An initiating stimulus (e.g., LPS from gram-negative bacteria in sepsis, gastric acid in aspiration) activates alveolar macrophages
  2. Activated macrophages release IL-1β, IL-6, IL-8 (CXCL8), and TNF-α
  3. IL-8 is a potent neutrophil chemoattractant — it recruits circulating neutrophils to the lung
  4. Neutrophils marginate against pulmonary capillary endothelium via upregulated adhesion molecules (E-selectin, ICAM-1)
  5. Transmigrated neutrophils release:
    • Reactive oxygen species (ROS) — oxidize lipid membranes, DNA, and proteins
    • Proteases (elastase, matrix metalloproteinases) — degrade the extracellular matrix and tight junctions
    • Platelet-activating factor and leukotrienes — amplify the inflammatory response
  6. This causes widespread alveolar epithelial and endothelial death → barrier failure

Coagulation and Vascular Mechanisms

  • Intravascular fibrin deposition in pulmonary capillaries causes microvascular obstruction
  • Fibrin is also deposited in alveolar spaces, contributing to hyaline membrane formation
  • Activated neutrophils and platelets further promote a prothrombotic, anti-fibrinolytic state in the lung
  • These vascular changes contribute to pulmonary hypertension, alongside hypoxic vasoconstriction and mechanical compression of vessels by positive-pressure ventilation

Surfactant Dysfunction

  • Phospholipase A2 (released systemically in pancreatitis, and locally in other triggers) enzymatically degrades surfactant
  • Protein-rich edema fluid in alveoli also directly inactivates surfactant
  • Loss of surfactant increases surface tension, causing alveolar collapse, reduced compliance, and worsening intrapulmonary shunt

Physiological Consequences

MechanismPhysiological Effect
Alveolar flooding + collapse↓ FRC, ↓ lung compliance
Right-to-left shunting through flooded alveoliRefractory hypoxemia (PaO₂/FiO₂ < 300 mmHg)
Dead space ventilationHypercapnia despite high minute ventilation
Microvascular obstruction + hypoxic vasoconstrictionPulmonary hypertension → RV strain
Surfactant lossFurther alveolar instability and collapse
Dead space is significantly increased in ARDS — ventilated alveoli lack perfusion due to microvascular obstruction, while perfused alveoli lack ventilation due to flooding, yielding both V/Q mismatch and true shunt. — Murray & Nadel's

Biotrauma and Ventilator-Induced Lung Injury (VILI)

Mechanical ventilation itself can perpetuate ARDS through biotrauma:
  • High tidal volumes overstretch the relatively small population of aerated alveoli (the "baby lung"), releasing cytokines (IL-6, IL-8, TNF-α) locally
  • These cytokines translocate into the systemic circulation, driving multiorgan failure
  • This is why most ARDS deaths are caused by sepsis and multiorgan failure, not by refractory hypoxemia per se — Murray & Nadel's

Summary Cascade

Trigger (sepsis, aspiration, trauma, etc.)
        ↓
Alveolar macrophage activation → proinflammatory cytokines (IL-1β, TNF-α, IL-8)
        ↓
Neutrophil recruitment → ROS + proteases + PAF
        ↓
Endothelial + epithelial barrier disruption
        ↓
Protein-rich exudate floods alveoli
        ↓
Surfactant dysfunction → alveolar collapse
        ↓
Hyaline membrane formation (DAD)
        ↓
Severe V/Q mismatch + shunt → refractory hypoxemia
        ↓
Pulmonary hypertension + dead space ventilation
        ↓
(Persistent) → fibroproliferation and fibrosis
Key point: ARDS is ultimately a dysregulated, amplified inflammatory response that destroys the alveolar-capillary barrier. The injury is not self-limited — ongoing cytokine release, neutrophil activation, and (if injurious ventilation is used) mechanical stretch perpetuate the cycle until either resolution or fatal multiorgan failure occurs.
Murray & Nadel's Textbook of Respiratory Medicine; Goldman-Cecil Medicine
This is a shared conversation. Sign in to Orris to start your own chat.